IT solutions giant CDW (NASDAQ:CDW) reported stronger-than-expected fourth-quarter results for 2025, with revenue rising 6.3% to $5.51 billion and adjusted EPS of $2.57 surpassing forecasts. The performance underscores resilient corporate IT spending despite broader economic uncertainties.
Shareholders who backed Alvopetro Energy Ltd. five years ago have seen a remarkable 343% total return, fueled by robust earnings growth and substantial dividend payouts, significantly outpacing the stock's impressive 197% price appreciation.
As Bitcoin retreated toward $73,000, Cathie Wood's ARK Invest executed a strategic buying spree across six key crypto-linked equities, signaling continued conviction in the sector's long-term prospects despite recent volatility.
As Bitcoin stabilizes near $76,000, market analysts are looking beyond macroeconomics to investor psychology. Could deep-seated cognitive biases like anchoring and regret aversion be the hidden catalysts for the next major price move?
Old Dominion Freight Line reported fourth-quarter revenue in line with Wall Street estimates at $1.31 billion, though sales declined 5.7% year-over-year. The less-than-truckload carrier's adjusted earnings of $1.09 per share modestly exceeded analyst consensus.
AbbVie (NYSE: ABBV) reported fourth-quarter 2025 revenue of $16.62 billion, a 10% year-over-year increase that surpassed Wall Street forecasts. Adjusted earnings per share of $2.71 also topped consensus estimates, signaling resilience in its growth strategy.
With $7.5M in total funding, Fibr AI uses autonomous AI agents to transform generic enterprise webpages into dynamic, one-to-one experiences, challenging the traditional agency-driven personalization model.
The industry's premier Ride & Drive event in Indianapolis will offer fleet managers hands-on experience with the latest Class 2-7 electric trucks, vans, and advanced internal combustion models, highlighting a pivotal moment for commercial transportation.
With its explosive earnings growth and modest executive pay, Matachewan Consolidated Mines (CVE:MCM.A) is catching the eye of investors seeking turnaround stories. But beneath the impressive headline numbers lie questions about sustainability and risk in this CA$3.7 million market cap venture.
A new report reveals a silent shift in American retirement: nearly half of all spousal caregivers are now seniors aged 75 or older. This trend, fueled by an aging population and shrinking family support networks, is forcing couples to confront daunting emotional and financial challenges rarely planned for.
Facing mounting pressure from rivals and U.S. pricing policies, Novo Nordisk warns of its first annual sales decline since 2017, sending its stock tumbling and forcing a strategic overhaul.
Oaktree Specialty Lending (OCSL) reported fourth-quarter revenue in line with Wall Street expectations at $75.1 million, though sales declined 13.3% year-over-year. Non-GAAP earnings per share of $0.06 fell sharply below analyst consensus, highlighting challenges in the current lending environment.
Shares of The Ensign Group (ENSG) have retreated from recent highs, closing at $173.60, prompting a fresh look at its valuation. While a lofty P/E ratio suggests the stock is richly priced, a discounted cash flow model points to potential upside, leaving investors to weigh conflicting signals against the backdrop of strong long-term shareholder returns.
Analysts have nudged RWE's fair value estimate higher to €53.74, a subtle reset driven by fine-tuning discount rates rather than a fundamental story change. This quiet calibration, against steady growth forecasts, underscores how incremental shifts shape the long-term investment thesis for the energy giant.
Avery Dennison (NYSE: AVY) reported fourth-quarter revenue of $2.27 billion, a 3.9% year-over-year increase that fell short of Wall Street expectations. However, adjusted earnings per share of $2.45 surpassed consensus estimates by 2.9%, highlighting a quarter of resilient profitability amid challenging market conditions.
GE HealthCare Technologies posted stronger-than-expected fourth-quarter revenue of $5.70 billion, a 7.1% year-over-year increase, while adjusted earnings per share of $1.44 also edged past analyst consensus. The performance highlights steady demand for its medical imaging and pharmaceutical diagnostics units amid ongoing healthcare capital investment.
Agribusiness giant Bunge Global (NYSE:BG) posted a blockbuster fourth quarter, with revenue surging 75.5% year-over-year to $23.76 billion, significantly exceeding analyst expectations. The performance highlights early gains from its transformative merger with Viterra, even as the company navigates a complex global landscape.
Cryptocurrency prices stabilized following the passage of a stopgap funding bill in Washington, ending a brief government shutdown. Bitcoin clawed back from a dip below $73,000, yet analysts warn the reprieve may be temporary with another fiscal deadline looming in two weeks.
As Ethereum's price plunges to $2,273, treasury firm Bitmine faces massive unrealized losses on its 3.7 million ETH holdings, triggering a decline in its BMNR stock. Chairman Tom Lee attributes the drawdown to broad market weakness and reaffirms the company's long-term accumulation strategy.
Facing intensifying competition for its blockbuster drugs Wegovy and Ozempic, Danish pharmaceutical leader Novo Nordisk has issued a sobering sales outlook for 2026, projecting its first annual decline since 2017 and triggering a sharp stock sell-off.
